calendar
3,969 catalysts · 3,316 8k filing · 577 earnings · 172 phase 2 completion · 93 drug shortage · 73 phase 1 completion · 62 phase 2 initiation
next 91 dayslessmore
MonWedFri
3,969 catalysts · 3,316 8k filing · 577 earnings · 172 phase 2 completion · 93 drug shortage · 73 phase 1 completion · 62 phase 2 initiation
Items: 5.02, 7.01, 9.01
Items: 1.01, 9.01
Items: 7.01, 9.01
Items: 2.02, 9.01
Items: 2.02, 7.01, 9.01
Items: 1.01, 7.01, 9.01
Items: 8.01, 9.01
Items: 8.01, 9.01
Items: 8.01, 9.01
Items: 7.01, 9.01
Items: 7.01, 8.01, 9.01
Items: 5.02, 9.01
Items: 1.01, 3.02, 8.01, 9.01
Items: 7.01, 8.01, 9.01
Items: 3.02, 9.01
Items: 2.02, 9.01
Items: 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, 9.01
Items: 2.02, 7.01
Items: 5.02
Items: 2.02, 9.01
Items: 8.01, 9.01
Items: 5.02, 9.01
Items: 8.01
Items: 5.02
Items: 7.01, 9.01
Items: 7.01, 9.01
Items: 5.02
Items: 5.02
Items: 8.01
Items: 2.02, 9.01
Items: 1.01
Items: 5.02
Items: 3.01
Items: 1.01, 3.02, 5.01, 5.02, 5.03, 5.07, 9.01
Items: 3.01, 7.01, 9.01
Items: 8.01, 9.01
Therapy area: Metabolic Disorders. Indication: Type 1 Diabetes (Juvenile Diabetes)
Therapy area: Oncology. Indication: Hepatocellular Carcinoma, Liver Cancer
Therapy area: Oncology. Indication: Cervical Cancer, Colorectal Cancer, Cutaneous Squamous Cell Carcinoma (cSCC), Esophageal Cancer, Esophageal Squamous Cell Carcinoma (ESCC), Gastric Cancer, Head And Neck Cancer, Head And Neck Squamous Cell Carcinoma (HNSC), Hepatocellular Carcinoma, Hypopharyngeal Cancer, Laryngeal Cancer, Malignant Pleural Mesothelioma, Melanoma, Non-Small Cell Lung Carcinoma, Oral Cancer, Oral Cavity (Mouth) Cancer, Oropharyngeal Cancer, Ovarian Cancer, Pancreatic Cancer, Re
Therapy area: Cardiovascular. Indication: Cerebrovascular Disease, Ischemia
Therapy area: Hematological Disorders. Indication: Hemophilia A (Factor VIII Deficiency)
Therapy area: Oncology. Indication: Breast Cancer, Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer), Metastatic Breast Cancer
Therapy area: Infectious Disease. Indication: Coronavirus Disease 2019 (COVID-19)
Therapy area: Metabolic Disorders. Indication: Phenylketonuria (PKU)
Therapy area: Cardiovascular. Indication: Ischemic Stroke
Therapy area: Oncology. Indication: Multiple Myeloma (Kahler Disease), Plasma Cell Neoplasm, Refractory Multiple Myeloma, Relapsed Multiple Myeloma
Therapy area: Nutritional Disorders. Indication: Unspecified Nutritional Disorders
Therapy area: Ophthalmology. Indication: Cataract, Fuchs Endothelial Corneal Dystrophy (FECD)
Therapy area: Gastrointestinal, Genetic Disorders, Hematological Disorders, Respiratory. Indication: Cytopenia, Liver Fibrosis, Mutational Disorders, Pulmonary Fibrosis
Therapy area: Infectious Disease, Mouth and Dental Disorders. Indication: Periodontitis, Unspecified Infectious Diseases